Commerce Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,853
Closed -$892K 1206
2021
Q2
$892K Buy
4,853
+20
+0.4% +$3.43K 0.01% 648
2021
Q1
$739K Buy
4,833
+14
+0.3% +$2.17K 0.01% 687
2020
Q4
$753K Sell
4,819
-545
-10% -$70K 0.01% 647
2020
Q3
$613K Sell
5,364
-286
-5% -$30.9K 0.01% 633
2020
Q2
$634K Buy
5,650
+1,439
+34% +$153K 0.01% 599
2020
Q1
$378K Buy
4,211
+706
+20% +$69.3K ﹤0.01% 681
2019
Q4
$379K Buy
3,505
+21
+0.6% +$2.25K ﹤0.01% 741
2019
Q3
$341K Buy
3,484
+117
+3% +$13.2K ﹤0.01% 736
2019
Q2
$441K Buy
3,367
+746
+28% +$96.1K ﹤0.01% 643
2019
Q1
$355K Sell
2,621
-927
-26% -$115K ﹤0.01% 669
2018
Q4
$345K Buy
3,548
+1,248
+54% +$148K ﹤0.01% 646
2018
Q3
$320K Buy
2,300
+548
+31% +$68.7K ﹤0.01% 718
2018
Q2
$218K Buy
+1,752
New +$205K ﹤0.01% 815
2016
Q1
Sell
-1,169
Closed -$223K 814
2015
Q4
$223K Sell
1,169
-260
-18% -$45.4K ﹤0.01% 731
2015
Q3
$223K Buy
+1,429
New +$261K ﹤0.01% 732
2013
Q3
Sell
-2,452
Closed -$226K 787
2013
Q2
$226K Buy
+2,452
New +$236K ﹤0.01% 686

Other funds holding ALXN